Literature DB >> 22814657

The future of orphan drug development.

J Woodcock1.   

Abstract

Mesh：

Year:  2012        PMID： 22814657     DOI： 10.1038/clpt.2012.89

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN： 0009-9236            Impact factor:   6.875


× No keyword cloud information.
  3 in total

1.  Emerging Genetic Counselor Roles within the Biotechnology and Pharmaceutical Industries: as Industry Interest Grows in Rare Genetic Disorders, How are Genetic Counselors Joining the Discussion?

Authors:  Tessa Field; Stephanie Jo Brewster; Meghan Towne; MaryAnn W Campion
Journal:  J Genet Couns       Date:  2016-03-28       Impact factor: 2.537

2.  Assessment of Clinical Trials Supporting US Food and Drug Administration Approval of Novel Therapeutic Agents, 1995-2017.

Authors:  Audrey D Zhang; Jeremy Puthumana; Nicholas S Downing; Nilay D Shah; Harlan M Krumholz; Joseph S Ross
Journal:  JAMA Netw Open       Date:  2020-04-01

3.  Precision Medicines' Impact on Orphan Drug Designation.

Authors:  Christine M Mueller; Gayatri R Rao; Katherine I Miller Needleman
Journal:  Clin Transl Sci       Date:  2019-07-26       Impact factor: 4.689
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.